Indeed, in a mitral valve regurgitation-induced heart failure model in dogs, metoprolol (β1-AR antagonist) administration prevented oxidation of sGC and promoted β3-AR/sGC-NO-cGMP coupling in specific membrane microdomains, but away from caveolae. Here, ADRB3 is linked to heart failure.